Biomea Fusion Statistics

Total Valuation

Biomea Fusion has a market cap or net worth of $389.06 million. The enterprise value is $221.76 million.

Market Cap	389.06M
Enterprise Value	221.76M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Biomea Fusion has 35.40 million shares outstanding. The number of shares has increased by 16.52% in one year.

Shares Outstanding	35.40M
Shares Change (YoY)	+16.52%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	25.18%
Owned by Institutions (%)	87.10%
Float	19.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.30
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.84, with a Debt / Equity ratio of 0.06.

Current Ratio	7.84
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.40% and return on invested capital (ROIC) is -70.26%.

Return on Equity (ROE)	-69.40%
Return on Assets (ROA)	-59.60%
Return on Capital (ROIC)	-70.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.40% in the last 52 weeks. The beta is -0.54, so Biomea Fusion's price volatility has been lower than the market average.

Beta (1Y)	-0.54
52-Week Price Change	-63.40%
50-Day Moving Average	15.17
200-Day Moving Average	15.15
Relative Strength Index (RSI)	32.93
Average Volume (30 Days)	1,054,264

Short Selling Information

The latest short interest is 13.24 million, so 37.39% of the outstanding shares have been sold short.

Short Interest	13.24M
Short Previous Month	11.20M
Short % of Shares Out	37.39%
Short % of Float	68.30%
Short Ratio (days to cover)	10.40

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-126.14M
Pretax Income	-117.26M
Net Income	-117.26M
EBITDA	-113.05M
EBIT	-117.26M
Earnings Per Share (EPS)	-$3.44

Full Income Statement

Balance Sheet

The company has $177.24 million in cash and $10.30 million in debt, giving a net cash position of $166.94 million or $4.72 per share.

Cash & Cash Equivalents	177.24M
Total Debt	10.30M
Net Cash	166.94M
Net Cash Per Share	$4.72
Equity / Book Value	169.24M
Book Value Per Share	4.78
Working Capital	156.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$96.59 million and capital expenditures -$3.37 million, giving a free cash flow of -$99.96 million.

Operating Cash Flow	-96.59M
Capital Expenditures	-3.37M
Free Cash Flow	-99.96M
FCF Per Share	-$2.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomea Fusion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.52%
Shareholder Yield	-16.52%
Earnings Yield	-30.17%
FCF Yield	-25.72%

Analyst Forecast

The average price target for Biomea Fusion is $47.09, which is 327.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$47.09
Price Target Difference	327.70%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-0.62%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2